Your browser doesn't support javascript.
loading
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
Veneti, Lamprini; Bøås, Håkon; Bråthen Kristoffersen, Anja; Stålcrantz, Jeanette; Bragstad, Karoline; Hungnes, Olav; Storm, Margrethe Larsdatter; Aasand, Nina; Rø, Gunnar; Starrfelt, Jostein; Seppälä, Elina; Kvåle, Reidar; Vold, Line; Nygård, Karin; Buanes, Eirik Alnes; Whittaker, Robert.
Afiliação
  • Veneti L; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
  • Bøås H; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Bråthen Kristoffersen A; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
  • Stålcrantz J; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Bragstad K; European Program for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Hungnes O; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
  • Storm ML; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
  • Aasand N; Department of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
  • Rø G; Department of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
  • Starrfelt J; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
  • Seppälä E; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
  • Kvåle R; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Vold L; Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
  • Nygård K; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Buanes EA; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
  • Whittaker R; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
Euro Surveill ; 27(4)2022 01.
Article em En | MEDLINE | ID: mdl-35086614

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article